Thank you for your interest in our whitepaper “The Promise of Precision Medicine for Cardiovascular Disease & The Potential Impact on Clinical Trials” You can access your copy here.
Introducing Medpace’s Cardiovascular Precision Medicine Program
At Medpace, we recognize the importance of the emerging role of precision medicine in the field of cardiovascular disease. To optimize support in the design and execution of cardiovascular clinical trials that employ a precision medicine strategy, we have initiated a Cardiovascular Precision Medicine Program (CVPMP). As an extension of the Cardiovascular Division, the CVPMP is comprised of cardiovascular experts with extensive knowledge in the field of precision medicine, who aim to create a highly specialized partnership with industry sponsors seeking to develop therapies focused on disease subphenotypes and employ a patient-tailored approach. Medpace continues to lead the CRO industry in the early recognition of major clinical currents to generate nimble responses for the development of safe and effective medical therapies.